| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |